Pitcairn CO Incyte Corp Transaction History

Pitcairn CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 02, 2018	SELL	$60.85 - $83.98 $312,221 - $430,901	-5,131 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$83.06 - $100.98 $40,201 - $48,874	-484 Reduced 8.62%	5,131 $427,000
Q4 2017 Feb 13, 2018	BUY	$93.56 - $116.6 $85,888 - $107,038	918 Added 19.54%	5,615 $531,000
Q3 2017 Nov 03, 2017	BUY	$109.15 - $138.27 $512,677 - $649,454	4,697	4,697 $549,000

642

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

Stay updated on Pitcairn CO with notifications on news.